Sign In
Buy TMDX
$75.74
+4.51 (+6.33%)
At Close: Jul 13, 2026
TransMedics Completes PAD Aviation Investment to Expand in Europe
01:45pm, Tuesday, 07'th Jul 2026
TMDX's PAD Aviation investment expands its OCS model into Europe, aiming to boost organ logistics, utilization and adoption.
Strata Critical Medical: A Better Alternative To TransMedics In Organ Transplant Logistics
08:15am, Tuesday, 07'th Jul 2026
Strata Critical Medical is rated a buy, driven by expanding market share, operational efficiencies, and a comprehensive suite of transplant logistics and clinical services. SRTA's asset-light-to-moder
TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH
07:05am, Monday, 06'th Jul 2026
Strategic investment in Germany-based PAD Aviation, a premier European private aviation operator, lays the foundation for TransMedics to establish a dedicated organ transplantation air logistics netwo
Where Will TransMedics Group Stock Be in 10 Years?
11:15am, Friday, 03'rd Jul 2026
TransMedics is building more than a medical device business. Its Organ Care System and nationwide transplant logistics network create a difficult-to-replicate competitive advantage.
3 Growth Stocks to Buy on the Dip
07:15pm, Thursday, 02'nd Jul 2026
Investing in attractive stocks on the dip is a great way to earn above-average returns over the long run. The three stocks below have faced some challenges, but their prospects look fairly strong.
Reasons to Retain TransMedics Stock in Your Portfolio for Now
02:16pm, Tuesday, 30'th Jun 2026
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.
What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock Drop
05:19pm, Wednesday, 24'th Jun 2026
Specializing in organ preservation technology, this medical device innovator reported a notable insider sale amid ongoing sector challenges.
SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating TransMedics Group, Inc. (NASDAQ: TMDX) on behalf of investors who suffered losses and whether those losses may be rec
TransMedics: Why I'm Still Bullish After The Collapse
09:44am, Tuesday, 09'th Jun 2026
TransMedics (TMDX) faces decelerating revenue growth, margin pressure, and increased investment, yet maintains strong market share gains and competitive positioning. TMDX's logistics and clinical serv
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market
08:20am, Friday, 05'th Jun 2026
Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?
12:35pm, Thursday, 04'th Jun 2026
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock?
This Healthcare Infrastructure Stock Is Risky, But the Upside Looks Huge
06:00pm, Tuesday, 02'nd Jun 2026
TransMedics (TMDX +1.19%) has been hit hard as investors question margins, spending, and execution. But beneath the sell-off, the company's Organ Care System, aviation network, and National OCS Progra
Reasons to Retain TransMedics Stock in Your Portfolio for Now
02:01pm, Thursday, 28'th May 2026
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.
TransMedics: Despite Earnings Miss, Growth Story Remains Intact
01:28pm, Monday, 25'th May 2026
TransMedics remains a 'Strong Buy' despite a 50% stock decline and Q1 2026 earnings miss, supported by robust long-term growth initiatives. TMDX's portfolio expansion includes CHOPS as a complementary
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Thursday, 21'st May 2026
ANDOVER, Mass., May 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-st
